Skip to content
Research Article Open access CC BY 4.0

Angiopoietin-like Protein 3 AND Cardiovascular Disease: A Mini Review

Srinidhi Rai

Journal of Pharmaceutical Research International · pp. 169–172 · Published 22 Nov 2021

10.9734/jpri/2021/v33i51A33481

Abstract

Objective of the review is to explore the role of angiopoietin like 3 protein (ANGPTL3) as a risk factor for cardiovascular disease. ANGPTL3 (human), one member of the angiopoietin-like protein (ANGPTL) family, has been identified as an important regulator of lipid metabolism. Dyslipidemia, characterized by elevation of plasma low density lipoprotein cholesterol (LDL-C), triglyceride (TG) and reduction of plasma high density lipoprotein cholesterol (HDL-C), has been verified as a causal risk factor for cardiovascular diseases (CVD), leading to a high mortality rate in general population. There may be an association between ANGPTL3, dyslipidemia, diabetes and cardiovascular risk.

Angiopoietin -like 3 hyperlipidemia T2DM CVD

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

8

Page views

0

PDF downloads

1

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.